re: Ann: FDA Approval Of New Dual-Scored 150m... I agree, this is a great company with good products (I have been watching this since Halcygen acquired Mayne Pharma which was a great buy and it is nice to see their other products are increasing sales so hopefully MYX is less reliant on Doryx).
However the uncertainty with SUBACAP (see SUBACAP update announcement 15/12/11) being delayed past 30/6/12 due to further questions by the UK MHRA has IMO caused the SP to weaken (it rose to over 50c before the fall I think in the belief that SUBACAP news would be good).
Hopefully the news from FDA in regards to Phase III is more positive.
Ann: FDA Approval Of New Dual-Scored 150mg Doryx , page-6
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.38 |
Change
0.440(11.2%) |
Mkt cap ! $372.6M | |||
| Open | High | Low | Value | Volume |
| $4.40 | $4.79 | $4.18 | $2.649M | 590.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1271 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.44 | 1271 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |